14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LXRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Lexicon Pharmaceuticals stock price on Friday which ended trading at $1.74
(Updated on May 03, 2024)

Sell candidate since Mar 21, 2024 Loss -27.80% PDF

The Lexicon Pharmaceuticals stock price gained 2.35% on the last trading day (Friday, 3rd May 2024), rising from $1.70 to $1.74. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 22.34% from a day low at $1.65 to a day high of $2.02. The price has been going up and down for this period, and there has been a 5.45% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $10.17 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.55% during the next 3 months and, with a 90% probability hold a price between $0.597 and $1.75 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LXRX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lexicon Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.97. On a fall, the stock will find some support from the short-term average at $1.62. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -51.40%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Lexicon Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.65 and $1.62. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lexicon Pharmaceuticals finds support just below today's level at $1.65. If this is broken, then the next support from accumulated volume will be at $1.62 and $1.54.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.369 between high and low, or 22.34%. For the last week, the stock has had daily average volatility of 12.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LXRX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Lexicon Pharmaceuticals to open at $1.80, and during the day (based on 14 day Average True Range), to move between $1.57 and $1.91, which gives a possible trading interval of +/-$0.171 (+/-9.82%) up or down from last closing price. If Lexicon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 19.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.65 (5.17%) than the resistance at $1.98 (13.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lexicon Pharmaceuticals stock A Buy?

Lexicon Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.594 Sell Candidate Unchanged

Predicted Opening Price for Lexicon Pharmaceuticals of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.80 ( 3.61%) $1.74

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LXRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.17 24.80 %
R2 2.03 16.70 %
R1 1.94 11.71 %
Current price: 1.74
Support S1 1.66 -4.48 %
S2 1.58 -9.48 %
S3 1.43 -17.57 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.15 23.56 %
R2 2.04 17.24 %
R1 1.98 13.79 %
Current price 1.74
Support S1 1.65 -5.17%
S2 1.62 -6.90%
S3 1.54 -11.49%

FAQ

What is the symbol for Lexicon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Lexicon Pharmaceuticals is LXRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lexicon Pharmaceuticals Stock.

What's the current price of Lexicon Pharmaceuticals Stock?
As of the end of day on the May 03, 2024, the price of an Lexicon Pharmaceuticals (LXRX) share was $1.74.

What is the 52-week high and low for Lexicon Pharmaceuticals Stock?
The 52-week high for Lexicon Pharmaceuticals Stock is $3.79 and the 52-week low is $0.92.

What is the market capitalization of Lexicon Pharmaceuticals Stock?
As of the May 03, 2024, the market capitalization of Lexicon Pharmaceuticals is 418.603M.

When is the next earnings date for Lexicon Pharmaceuticals?
The upcoming earnings date for Lexicon Pharmaceuticals is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan... LXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT